Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Display:
?
Cancer Type/Condition:  Breast cancer, female
Stage/Subtype:  breast cancer in situ
Trial Type:  Treatment
Results 1-24 of 24 for your search:
Start Over
Safety and Efficacy Study of the Xoft® Axxent® eBx™ IORT System
Status: Active
Phase: Phase IV
Type: Treatment
Age: 40 and over
Trial IDs: CTPR-0009, NCI-2013-01601, NCT01644669
Study of the Efficacy of Chloroquine in the Treatment of Ductal Carcinoma in Situ (The PINC Trial)
Status: Active
Phase: Phase II, Phase I
Type: Treatment
Age: 18 and over
Trial IDs: IFHCC 09-002, NCI-2014-01429, NCT01023477
Accelerated Partial Breast Irradiation in Treating Patients with Low-Risk Stage 0-I Breast Cancer
Status: Active
Phase: Phase II, Phase I
Type: Treatment
Age: 50 and over
Trial IDs: 201401160, NCI-2014-00269, NCT02076074
Accelerated Whole Breast Radiotherapy in Treating Patients with Breast Cancer Who Have Undergone Surgery
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 040807, NCI-2012-00535, CDR0000643276, CINJ-040807, NCT00909909
High Dose Rate Brachytherapy in Treating Patients with Endometrial, Cervical, Lung, Breast, or Prostate Cancer
Status: Active
Phase: Phase II
Type: Natural history/Epidemiology, Treatment
Age: 18 to 90
Trial IDs: 09-C-0100, NCI-2013-01448, 090100, 302844, P08407, NCT00924027
Laboratory Treated T Cells after Chemotherapy in Treating Patients with HER2-Negative Stage II-III Breast Cancer That Can Be Removed by Surgery
Status: Temporarily closed
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 2010-056, NCI-2011-02634, 1005008403, CDR0000675211, NCT01658969, WSU-2010-056, NCT01147016
Radiation Therapy in Treating Patients With Breast Cancer
Status: Active
Phase: Phase II
Type: Treatment
Age: 18 and over
Trial IDs: 2009-0818, NCI-2011-01102, NCT01245712
PD 0332991 and Anastrozole for Stage 2 or 3 Estrogen Receptor Positive and HER2 Negative Breast Cancer
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: 201301106, NCI-2012-02202, NCT01723774
Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer
Status: Active
Phase: Phase II
Type: Treatment
Age: 50 and over
Trial IDs: BRE007-12, NCI-2016-00072, NCT01766297
Omega-3 Fatty Acid in Treating Patients with Stage I-III Breast Cancer
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: CCCWFU 98113, NCI-2013-00963, NCT01869764
Hypofractionated Regional Nodal Radiation Therapy in Treating Older Patients with Breast Cancer Who Have Undergone Surgery
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 50 and over
Trial IDs: MCC-15-10994, NCI-2015-01317, NCT02515110
Boost Radiation Therapy before Surgery in Treating Patients with Breast Cancer
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: Not specified
Trial IDs: Pro00063936, NCI-2015-01625, NCT02482389
Single-Fraction Partial Breast Radiation Therapy before Surgery in Treating Patients with Early Stage Breast Cancer
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 60 and over
Trial IDs: Pro00063848, NCI-2015-01856, NCT02482376
Nelipepimut-S Plus GM-CSF Vaccine Therapy in Treating Patients with Breast Cancer
Status: Not yet active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: MDA2014-04-02, NCI-2015-02189, HHSN261201200034I, N01-CN-2012-00034, NCT02636582
PK Study of Pre-Surgical Intramuscular and Intraductal Fulvestrant in Women With Invasive Breast Cancer or DCIS Undergoing Mastectomy
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: ATOS-2015-007, NCI-2016-00299, NCT02540330
Accelerated Partial Breast Radiation Therapy Using High-Dose Rate Brachytherapy in Treating Patients with Early Stage Breast Cancer after Surgery
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 45 and over
Trial IDs: 041404, NCI-2015-01156, Pro20150001297, NCT02526498
Conjugated Estrogens/Bazedoxifene in Treating Patients with Ductal Carcinoma in Situ Undergoing Surgery
Status: Not yet active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 to 75
Trial IDs: NU 15B06, NCI-2016-00066, STU00202100, NCT02694809
Letrozole with or without Ribociclib before Surgery in Treating Women with Stage II-III Estrogen Receptor-Positive, HER2-Negative Breast Cancer
Status: Active
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Age: 18 and over
Trial IDs: CLEE011XUS10T, NCI-2016-00423, STUDY00002972, NCT02712723
Radiofrequency Ablation After Breast Lumpectomy in Treating Patients With Breast Cancer
Status: Active
Phase: No phase specified
Type: Treatment
Age: 50 and over
Trial IDs: AAAF3783, NCI-2011-00746, NCT01153035
Black Cohosh in Treating Patients with Breast Ductal Carcinoma in Situ
Status: Active
Phase: No phase specified
Type: Supportive care, Treatment
Age: 18 and over
Trial IDs: 1205010204, NCI-2015-00920, NCT01628536
Caloric Restriction in Treating Patients with Early Stage Breast Cancer Undergoing Surgery and Radiation Therapy
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Supportive care, Treatment
Age: 18 and over
Trial IDs: 12G.616, NCI-2013-00611, 2012-94, NCT01819233
Study to Assess Perfusion and Patient Satisfaction in Nipple-Areola Mastectomy with Immediate Reconstruction
Status: Active
Phase: No phase specified
Type: Supportive care, Treatment
Age: 18 and over
Trial IDs: 201302004, NCI-2014-00013, NCT01969448
Metformin Hydrochloride and Atorvastatin Calcium in Treating Patients with Newly Diagnosed Breast Cancer That Can Be Removed by Surgery
Status: Active
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Age: 21 and over
Trial IDs: IRB-AAAM2306, NCI-2014-01506, AAAM2306, Y1M00, NCT01980823
Prone Breath Hold Technique in Decreasing Heart and Lung Radiation Doses in Patients with Breast Cancer Receiving Left Breast Radiation Therapy
Status: Active
Phase: No phase specified
Type: Health services research, Treatment
Age: 18 and over
Trial IDs: 1409500149, NCI-2015-01120, 1409500149A001, NCT02379988
Start Over